{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:15:54Z","timestamp":1793049354633,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.heliyon.2024.e39935","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T16:25:47Z","timestamp":1730305547000},"page":"e39935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluating CRMS\/CFSPID phenotypes and outcomes: A retrospective study from a large UK cystic fibrosis centre"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9575-735X","authenticated-orcid":false,"given":"Alison","family":"Mansfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4496-3613","authenticated-orcid":false,"given":"Christopher","family":"Hine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0837-0308","authenticated-orcid":false,"given":"Prasad","family":"Nagakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8441-4037","authenticated-orcid":false,"given":"Benjamin","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9928-866X","authenticated-orcid":false,"given":"Maya","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e39935_bib1","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S1569-1993(23)00354-5","article-title":"EPS7.04 Evaluating CFSPID phenotypes and outcomes a retrospective study from a large UK cystic fibrosis centre","volume":"22","author":"Mansfield","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.heliyon.2024.e39935_bib2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.prrv.2012.05.003","article-title":"The impact of newborn screening and earlier intervention on the clinical course of cystic fibrosis","volume":"13","author":"Dijk","year":"2012","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.heliyon.2024.e39935_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jcf.2016.12.012","article-title":"The expansion and performance of national newborn screening programmes for cystic fibrosis in Europe","volume":"16","author":"Barben","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.heliyon.2024.e39935_bib4","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcf.2020.11.006","article-title":"Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome\/cystic fibrosis screen positive, inconclusive diagnosis (CRMS\/CFSPID)","volume":"20","author":"Barben","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.heliyon.2024.e39935_bib5","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jpeds.2016.09.066","article-title":"Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome and cystic fibrosis screen positive, inconclusive diagnosis","volume":"181S","author":"Ren","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.heliyon.2024.e39935_bib6","doi-asserted-by":"crossref","first-page":"e1377","DOI":"10.1542\/peds.2014-2081","article-title":"Inconclusive diagnosis of cystic fibrosis after newborn screening","volume":"135","author":"Ooi","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.heliyon.2024.e39935_bib7","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ppul.24634","article-title":"Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening","volume":"55","author":"Munck","year":"2020","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.heliyon.2024.e39935_bib8","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-051740","article-title":"Outcomes of cystic fibrosis screening-positive infants with inconclusive diagnosis at school age","volume":"148","author":"Gonska","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.heliyon.2024.e39935_bib9","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41431-022-01054-5","article-title":"Receiving results of uncertain clinical relevance from population genetic screening: systematic review & meta-synthesis of qualitative research","volume":"30","author":"Johnson","year":"2022","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.heliyon.2024.e39935_bib10","article-title":"High rates of anxiety detected in mothers of children with inconclusive cystic fibrosis screening results","author":"Ginsburg","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.heliyon.2024.e39935_bib11","article-title":"European CF Society Neonatal Screening Working Group (ECFS NSWG), European survey of newborn bloodspot screening for CF: opportunity to address challenges and improve performance","author":"Munck","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.heliyon.2024.e39935_bib12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"STROBE initiative, the strengthening the reporting of observational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.heliyon.2024.e39935_bib13","doi-asserted-by":"crossref","DOI":"10.1183\/20734735.0088-2021","article-title":"Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome\/cystic fibrosis screen positive, inconclusive diagnosis (CRMS\/CFSPID)","volume":"17","author":"Sinha","year":"2021","journal-title":"Breathe"},{"key":"10.1016\/j.heliyon.2024.e39935_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jpeds.2007.03.002","article-title":"Diagnostic sweat testing: the cystic fibrosis foundation guidelines","volume":"151","author":"LeGrys","year":"2007","journal-title":"J. Pediatr."},{"key":"10.1016\/j.heliyon.2024.e39935_bib16","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2016.09.064","article-title":"Diagnosis of cystic fibrosis: consensus guidelines from the cystic fibrosis foundation","volume":"181S","author":"Farrell","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.heliyon.2024.e39935_bib17","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jcf.2015.01.001","article-title":"ECFS Neonatal Screening Working Group, Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): a new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening","volume":"14","author":"Munck","year":"2015","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.heliyon.2024.e39935_bib18","doi-asserted-by":"crossref","first-page":"c1140","DOI":"10.1136\/bmj.c1140","article-title":"Using the new UK-WHO growth charts","volume":"340","author":"Wright","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.heliyon.2024.e39935_bib19","author":"Vogel"},{"key":"10.1016\/j.heliyon.2024.e39935_bib20","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"ERS Global Lung Function Initiative, Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.heliyon.2024.e39935_bib21","author":"Lytras"},{"key":"10.1016\/j.heliyon.2024.e39935_bib22","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1183\/09031936.05.00059105","article-title":"The Chrispin-Norman score in cystic fibrosis: doing away with the lateral view","volume":"26","author":"Benden","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.heliyon.2024.e39935_bib24","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1542\/peds.2015-0811","article-title":"California cystic fibrosis newborn screening consortium, newborn screening for cystic fibrosis in California","volume":"136","author":"Kharrazi","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.heliyon.2024.e39935_bib25","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.jpeds.2015.01.052","article-title":"Long-term outcomes of children with intermediate sweat chloride values in infancy","volume":"166","author":"Groves","year":"2015","journal-title":"J. Pediatr."},{"key":"10.1016\/j.heliyon.2024.e39935_bib26","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jcf.2019.04.002","article-title":"Cystic fibrosis screen positive inconclusive diagnosis (CFSPID): experience in Tuscany, Italy","volume":"18","author":"Terlizzi","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.heliyon.2024.e39935_bib27","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.jcf.2021.06.012","article-title":"When CFSPID becomes CF","volume":"21","author":"Ginsburg","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.heliyon.2024.e39935_bib28","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jcf.2021.03.015","article-title":"A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS\/CFSPID) in six Italian centres","volume":"20","author":"Terlizzi","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.heliyon.2024.e39935_bib29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1526-0550(02)00003-3","article-title":"Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence","volume":"3","author":"Davies","year":"2002","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.heliyon.2024.e39935_bib30","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/ppul.26296","article-title":"Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS\/CFSPID to CF reclassification","volume":"58","author":"Salinas","year":"2023","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.heliyon.2024.e39935_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1127659","article-title":"Outcomes of children with cystic fibrosis screen positive, inconclusive diagnosis\/CFTR related metabolic syndrome","volume":"11","author":"Gunnett","year":"2023","journal-title":"Front Pediatr"},{"key":"10.1016\/j.heliyon.2024.e39935_bib32","article-title":"Biochemical and genetic tools to predict the progression to Cystic Fibrosis in CRMS\/CFSPID subjects: a systematic review","author":"Terlizzi","year":"2024","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.heliyon.2024.e39935_bib33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12887-019-1756-4","article-title":"Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis","volume":"19","author":"Ooi","year":"2019","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.heliyon.2024.e39935_bib34","doi-asserted-by":"crossref","first-page":"e1523","DOI":"10.1542\/peds.2005-3161","article-title":"Immunoreactive trypsin\/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels?","volume":"118","author":"Scotet","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.heliyon.2024.e39935_bib35","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/jmg.2009.067215","article-title":"The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening","volume":"46","author":"Thauvin-Robinet","year":"2009","journal-title":"J. Med. Genet."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402415966X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402415966X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T06:30:58Z","timestamp":1775457058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402415966X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":33,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S240584402415966X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39935","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating CRMS\/CFSPID phenotypes and outcomes: A retrospective study from a large UK cystic fibrosis centre","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e39935"}}